We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $34.1M invested in Cumberland Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $29.4M → $34.1M (+$4.71M)

0% more funds holding

Funds holding: 45 → 45 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
20
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$3.81M
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$1.46M
3
GHA
GW Henssler & Associates
Georgia
+$1.01M
4
Norges Bank
Norges Bank
Norway
+$109K
5
Two Sigma Investments
Two Sigma Investments
New York
+$71.2K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$2.36M
2
UCFA
United Capital Financial Advisors
Texas
-$1.09M
3
BG
BlackRock Group
United Kingdom
-$601K
4
Morgan Stanley
Morgan Stanley
New York
-$300K
5
Goldman Sachs
Goldman Sachs
New York
-$268K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$13M +$3.81M +779,805 +44%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$3.73M -$36.1K -7,403 -1%
BIT
3
BlackRock Institutional Trust
California
$3.08M -$2.36M -483,032 -44%
KIM
4
Kestrel Investment Management
California
$2.95M -$117K -24,000 -4%
New York State Common Retirement Fund
5
New York State Common Retirement Fund
New York
$1.52M +$1.46M +298,172 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.37M – – –
GHA
7
GW Henssler & Associates
Georgia
$1.06M +$1.01M +207,904 New
UCFA
8
United Capital Financial Advisors
Texas
$1.01M -$1.09M -223,904 -53%
Renaissance Technologies
9
Renaissance Technologies
New York
$682K -$216K -44,262 -25%
PCM
10
Perritt Capital Management
Illinois
$569K – – –
LSV Asset Management
11
LSV Asset Management
Illinois
$512K – – –
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$481K -$3.42K -700 -0.7%
Morgan Stanley
13
Morgan Stanley
New York
$463K -$300K -61,444 -40%
BA
14
Bard Associates
Illinois
$460K -$6.59K -1,350 -1%
BCM
15
Bridgeway Capital Management
Texas
$429K – – –
Invesco
16
Invesco
Georgia
$299K -$879 -180 -0.3%
GCP
17
GSA Capital Partners
United Kingdom
$285K +$25.9K +5,300 +11%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$219K +$771 +158 +0.4%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$200K – – –
Two Sigma Advisers
20
Two Sigma Advisers
New York
$198K +$6.35K +1,300 +3%
Two Sigma Investments
21
Two Sigma Investments
New York
$197K +$71.2K +14,585 +61%
BFA
22
BlackRock Fund Advisors
California
$194K +$7.76K +1,590 +4%
PP
23
PDT Partners
New York
$164K +$8.3K +1,700 +6%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$141K – – –
Northern Trust
25
Northern Trust
Illinois
$126K -$488 -100 -0.4%
1
2 3

CPIX Hedge Fund Activity: Q4 2013 in Review

45 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2013, worth a combined $34.1M — up 16% from $29.4M a quarter earlier.

Fund positioning in CPIX was balanced in Q4 2013: 6 funds opened new positions, 6 closed out, 9 added to existing stakes and 20 trimmed.

The largest buyer was Ariel Investments, adding an estimated $3.81M. The largest seller was BlackRock Institutional Trust, cutting an estimated $2.36M.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $34.1M of Cumberland Pharmaceuticals stock for Q4 2013, up 16% quarter-over-quarter.
  • 6 funds opened new Cumberland Pharmaceuticals positions in Q4 2013 and 6 closed out, a net change of 0 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2013 was Ariel Investments, an estimated $3.81M added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2013 was BlackRock Institutional Trust, an estimated $2.36M sold.

Based on aggregated 13F filings for Q4 2013.